Rhumbline Advisers Acquires 1,024 Shares of Paragon 28, Inc. (NYSE:FNA)

Rhumbline Advisers boosted its holdings in shares of Paragon 28, Inc. (NYSE:FNA) by 1.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,861 shares of the company’s stock after buying an additional 1,024 shares during the quarter. Rhumbline Advisers owned approximately 0.08% of Paragon 28 worth $649,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of FNA. JPMorgan Chase & Co. lifted its stake in shares of Paragon 28 by 2,141.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock worth $5,243,000 after buying an additional 749,865 shares during the last quarter. Stonepine Capital Management LLC bought a new position in Paragon 28 in the 3rd quarter valued at about $766,000. GSA Capital Partners LLP acquired a new stake in Paragon 28 during the third quarter worth approximately $386,000. Barclays PLC lifted its position in Paragon 28 by 180.6% during the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after acquiring an additional 54,591 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Paragon 28 by 7.0% during the third quarter. Wellington Management Group LLP now owns 694,799 shares of the company’s stock worth $4,641,000 after acquiring an additional 45,215 shares during the period. Institutional investors own 63.57% of the company’s stock.

Paragon 28 Price Performance

Paragon 28 stock opened at $13.03 on Friday. The firm has a market cap of $1.09 billion, a PE ratio of -17.60 and a beta of 1.54. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60. The stock’s fifty day moving average price is $12.07 and its two-hundred day moving average price is $9.33. Paragon 28, Inc. has a one year low of $4.65 and a one year high of $13.13.

Insider Transactions at Paragon 28

In related news, major shareholder Mvm Partners, Llc sold 164,664 shares of the company’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $13.01, for a total transaction of $2,142,278.64. Following the completion of the sale, the insider now owns 8,854,883 shares of the company’s stock, valued at $115,202,027.83. This represents a 1.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last three months, insiders have sold 831,689 shares of company stock valued at $10,742,364. 15.32% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Stephens reiterated an “equal weight” rating and set a $13.00 target price (down previously from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Needham & Company LLC reiterated a “hold” rating and set a $13.00 price objective on shares of Paragon 28 in a research report on Wednesday, January 29th. Canaccord Genuity Group set a $13.00 target price on shares of Paragon 28 in a research report on Wednesday, January 29th. Finally, William Blair downgraded shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $14.20.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.